ISPE Announces 2026-2027 ISPE International Board of Directors Election Results

The 2026–2027 ISPE International Board of Directors has been announced. Newly elected Directors will assume their positions at the 2026 ISPE Annual Meeting & Expo.

NORTH BETHESDA, Md., Sept. 29, 2026 /PRNewswire/ -- The International Society for Pharmaceutical Engineering (ISPE) has announced the results of the 2026–2027 ISPE International Board of Directors election.

The ISPE International Board of Directors is responsible for the governance and strategic direction of ISPE. Board members will assume their elected positions at the 2026 ISPE Annual Meeting & Expo, taking place in Washington, D.C., USA, and virtually from 18 to 21 October.

The following pharmaceutical industry leaders have been elected to positions on the 2026–2027 ISPE International Board of Directors.

Executive Committee:

• Chair: Ylva Ek, Founder, Robur Life Science Advisory AB 
• Vice Chair: David Churchward, Head of Operations Quality Compliance and External Affairs, AstraZeneca
• Treasurer: Georg Singewald, PhD, Global Head of Quality and Compliance, Roche/Genentech
• Secretary: Gunter Baumgartner, Senior Vice President, Head of Global Engineering, Takeda Pharmaceuticals International AG
• Past Chair: Vivianne Arencibia, Vice President, Head of Quality Auditing and Risk Management, Lonza AG

Newly Elected and Re-Elected Directors:

• Michele Ghinizzini, Senior Vice President Global Head of Engineering and Maintenance, Sanofi
• Paige Kane, PhD, Associate Vice President Technical Excellence and Transformation, CAI
• Shanshan Liu, Global Process Science and Regulator Director, Fedegari
• Vivien Santillan, Regional Director, Asia, Novatek International

The following Directors were elected in 2025 to serve a two-year term and will continue their service on the Board.

Directors Continuing a Term in 2026–2027:

• Jose Caraballo-Oramas, Founder and Principal, JCO Global Advisory LLC
• Liz Dooley, Senior Director, Global Engineering and Technology, Johnson & Johnson 
• Francesco Intoccia, Senior Vice President, Global Engineering, EHS and Sustainability, GSK

Board Members Completing Service

• Jeffrey Biskup, Chair 2024-2025 and Immediate Past Chair, Executive Chairman of the Board, CRB
• Victor Cruz, Senior Vice President of Corporate Engineering and Global Health, Safety and Environmental, Eli Lilly and Company
• Norman Goldschmidt, President, Genesis AEC 
• James Grunwald, Senior Vice President US Business Development, Arcadis

The election was run by an independent third party, which provided ISPE with the final audited results.

To learn more about ISPE, visit ISPE.org. To register for the upcoming 2026 ISPE Annual Meeting & Expo, visit ISPE.org/AM26.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 25,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ispe-announces-20262027-ispe-international-board-of-directors-election-results-302892010.html

SOURCE ISPE